日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Treatment strategies for small cell carcinoma of the esophagus: comparative analysis of multimodal regimens in two independent real-world cohorts

食管小细胞癌的治疗策略：两个独立真实世界队列中多模式治疗方案的比较分析

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyag115
Yin, Xiaolei; Li, Xiaopeng; Mi, Lili; Hou, Jiaojiao; Yin, Fei
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

A blood-biomarker based CTC-ALRI score predicts recurrence in hepatocellular carcinoma patients following curative resection

基于血液生物标志物的CTC-ALRI评分可预测肝细胞癌患者根治性切除术后的复发情况

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2026.1788776
Wang, Jinfeng; Han, Guangjie; Han, Xin; Shi, Jianfei; Mi, Lili; Li, Ning; Zhao, Man; Duan, Xiaoling; Yin, Fei
细胞生物学
肿瘤
肿瘤免疫
ALR
发表日期：2026
文献求助 收藏

Single-cell transcriptomic analysis reveals epithelial and microenvironmental heterogeneity in small cell carcinoma of the esophagus

单细胞转录组分析揭示食管小细胞癌的上皮和微环境异质性

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1672587
Yin, Xiaolei; Li, Xiaopeng; Mi, Lili; Hou, Jiaojiao; Yin, Fei
细胞生物学
肿瘤
肿瘤免疫
单细胞
发表日期：2025
文献求助 收藏

Exosome-related immune signatures and peripheral blood assays predict prognosis and immunotherapy response in hepatocellular carcinoma

外泌体相关免疫特征和外周血检测可预测肝细胞癌的预后和免疫治疗反应

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2025.1696790
Gao, Ruolian; Mi, Lili; Shi, Jianfei; Zhang, Meng; Duan, Xiaoling; Zhao, Man; Yin, Fei
外泌体
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

TOP2A as a prognostic biomarker in small cell carcinoma of the esophagus: an integrated bioinformatics and immunohistochemical study

TOP2A作为食管小细胞癌的预后生物标志物：一项整合生物信息学和免疫组织化学的研究

期刊:Frontiers in Molecular Biosciences
影响因子:4
doi:10.3389/fmolb.2025.1640881
Yin, Xiaolei; Li, Xiaopeng; Mi, Lili; Hou, Jiaojiao; Yin, Fei
肿瘤
IHC
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Aberrant activation of the PI3K/AKT/HIF‑1α pathway promotes glycolysis and lenvatinib resistance in liver cancer.

PI3K/AKT/HIF-1α通路异常激活促进肝癌中的糖酵解和乐伐替尼耐药性

期刊:Molecular Medicine Reports
影响因子:3.5
doi:10.3892/mmr.2025.13666
Wang Jinfeng, Shi Jianfei, Mi Lili, Zhao Man, Han Guangjie, Yin Fei
肿瘤
肝癌
PI3K/Akt
发表日期：2025
文献求助 收藏

Development and validation of a prognostic model for overall survival in small cell carcinoma of the esophagus

食管小细胞癌总生存期预后模型的建立与验证

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1540691
Yin, Xiaolei; Li, Xiaopeng; Mi, Lili; Hou, Jiaojiao; Yin, Fei
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

The value of blood lactate and lactate clearance rate in evaluating the prognosis of athletes with heat illness of varying degrees after high-intensity exercise

高强度运动后不同程度热疾病运动员的预后评估中，血乳酸和乳酸清除率的价值

期刊:BMC Sports Science Medicine and Rehabilitation
影响因子:2.8
doi:10.1186/s13102-024-01042-w
Yu, Li; Dong, Xuehui; Li, Huanhuan; Mi, Lili
发表日期：2025
文献求助 收藏

Correction: The value of blood lactate and lactate clearance rate in evaluating the prognosis of athletes with heat illness of varying degrees after high-intensity exercise

更正：高强度运动后不同程度热疾病运动员的预后评估中，血乳酸和乳酸清除率的价值

期刊:BMC Sports Science Medicine and Rehabilitation
影响因子:2.8
doi:10.1186/s13102-025-01318-9
Yu, Li; Dong, Xuehui; Li, Huanhuan; Mi, Lili
发表日期：2025
文献求助 收藏

Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance.

在 HCC 中鉴定和验证与乐伐替尼耐药性相关的预后特征，其中 PFKFB4 促进肿瘤进展和乐伐替尼耐药性

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-025-03861-8
Wang Jinfeng, Shi Jianfei, Mi Lili, Li Ning, Han Xin, Zhao Man, Duan Xiaoling, Han Guangjie, Hou Jiaojiao, Yin Fei
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏